Fibromyal Relief
Natural health product licensed in Canada
- Other names
- Fibromyal Care, Fibromyal Support, Fibromyal-Aid
- Licence holder
- Ovensa Inc.
- NPN or DIN-HM
- 80088791
- Status
- Active licence
- Licence date
- 18 October 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poly-bêta-(1,4)-2-amino-2-désoxy-d-glucose | 300 mg | Not calculated |
| Cannabis sativa Source : Graine(s) | 100 mg | Not calculated |
| L-5-hydroxytryptophane | 100 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 3 days |
Uses authorised in Canada
Helps to relieve symptoms of fibromyalgia. Helps to reduce the severity and duration of migraine headaches when taken as a prophylactic. Helps to promote healthy mood balance.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you have an allergy to seafood, do not use this product. If you are pregnant or breastfeeding, do not use. Do not use if you have scleroderma.
- Effets indésirables connus
May cause abdominal pain, bloating, constipation, indigestion and/or diarrhea. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
- Précautions et mises en garde
If you are taking blood thinners, consult a health care practitioner prior to use. Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes.
Source
Official Health Canada record, licence 80088791
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.